| Baseline characteristics . | N = 1124 . |
|---|---|
| Male (%) | 87 |
| Age (years) | 63 ± 13 |
| Age > 60 years (%) | 70 |
| Weight (kg) | 89 ± 17 |
| Height (cm) | 175 ± 9 |
| Body mass index (kg/m2) | 29 ± 5 |
| Body surface area (m2) | 2.0 ± 0.2 |
| Congestive heart failure (%) | 93 |
| CHA2DS2-VASc score | 3.6 ± 1.7 |
| Implantable cardioverter-defibrillator (%) | 78 |
| Cardiac resynchronisation therapy (%) | 35 |
| Arterial hypertension (%) | 66 |
| Diabetes mellitus (%) | 31 |
| Stroke/transient ischaemic attack (%) | 12 |
| Coronary (or peripheral) artery disease (%) | 68 |
| Chronic obstructive pulmonary disease (%) | 12 |
| NYHA Class | 2.0 ± 1.0 |
| NYHA Class ≥ III (%) | 31 |
| Left ventricular ejection fraction (%) | 34 ± 12 |
| Left ventricular ejection fraction < 25% (%) | 25 |
| Serum creatinine (μmol/L) | 112 ± 48 |
| Electrical storm (%) | 25 |
| PAINESD score | 11.4 ± 6.6 |
| Type of cardiomyopathy | |
| Ischaemic cardiomyopathy (%) | 67 |
| Dilated cardiomyopathy (%) | 18 |
| Arrhythmogenic cardiomyopathy (%) | 5 |
| Hypertrophic cardiomyopathy (%) | 1 |
| Valvular cardiomyopathy (%) | 11 |
| Other cardiomyopathy (%) | 13 |
| Baseline characteristics . | N = 1124 . |
|---|---|
| Male (%) | 87 |
| Age (years) | 63 ± 13 |
| Age > 60 years (%) | 70 |
| Weight (kg) | 89 ± 17 |
| Height (cm) | 175 ± 9 |
| Body mass index (kg/m2) | 29 ± 5 |
| Body surface area (m2) | 2.0 ± 0.2 |
| Congestive heart failure (%) | 93 |
| CHA2DS2-VASc score | 3.6 ± 1.7 |
| Implantable cardioverter-defibrillator (%) | 78 |
| Cardiac resynchronisation therapy (%) | 35 |
| Arterial hypertension (%) | 66 |
| Diabetes mellitus (%) | 31 |
| Stroke/transient ischaemic attack (%) | 12 |
| Coronary (or peripheral) artery disease (%) | 68 |
| Chronic obstructive pulmonary disease (%) | 12 |
| NYHA Class | 2.0 ± 1.0 |
| NYHA Class ≥ III (%) | 31 |
| Left ventricular ejection fraction (%) | 34 ± 12 |
| Left ventricular ejection fraction < 25% (%) | 25 |
| Serum creatinine (μmol/L) | 112 ± 48 |
| Electrical storm (%) | 25 |
| PAINESD score | 11.4 ± 6.6 |
| Type of cardiomyopathy | |
| Ischaemic cardiomyopathy (%) | 67 |
| Dilated cardiomyopathy (%) | 18 |
| Arrhythmogenic cardiomyopathy (%) | 5 |
| Hypertrophic cardiomyopathy (%) | 1 |
| Valvular cardiomyopathy (%) | 11 |
| Other cardiomyopathy (%) | 13 |
Data are provided as means ± SD or percentages.
NYHA, New York Heart Association.
| Baseline characteristics . | N = 1124 . |
|---|---|
| Male (%) | 87 |
| Age (years) | 63 ± 13 |
| Age > 60 years (%) | 70 |
| Weight (kg) | 89 ± 17 |
| Height (cm) | 175 ± 9 |
| Body mass index (kg/m2) | 29 ± 5 |
| Body surface area (m2) | 2.0 ± 0.2 |
| Congestive heart failure (%) | 93 |
| CHA2DS2-VASc score | 3.6 ± 1.7 |
| Implantable cardioverter-defibrillator (%) | 78 |
| Cardiac resynchronisation therapy (%) | 35 |
| Arterial hypertension (%) | 66 |
| Diabetes mellitus (%) | 31 |
| Stroke/transient ischaemic attack (%) | 12 |
| Coronary (or peripheral) artery disease (%) | 68 |
| Chronic obstructive pulmonary disease (%) | 12 |
| NYHA Class | 2.0 ± 1.0 |
| NYHA Class ≥ III (%) | 31 |
| Left ventricular ejection fraction (%) | 34 ± 12 |
| Left ventricular ejection fraction < 25% (%) | 25 |
| Serum creatinine (μmol/L) | 112 ± 48 |
| Electrical storm (%) | 25 |
| PAINESD score | 11.4 ± 6.6 |
| Type of cardiomyopathy | |
| Ischaemic cardiomyopathy (%) | 67 |
| Dilated cardiomyopathy (%) | 18 |
| Arrhythmogenic cardiomyopathy (%) | 5 |
| Hypertrophic cardiomyopathy (%) | 1 |
| Valvular cardiomyopathy (%) | 11 |
| Other cardiomyopathy (%) | 13 |
| Baseline characteristics . | N = 1124 . |
|---|---|
| Male (%) | 87 |
| Age (years) | 63 ± 13 |
| Age > 60 years (%) | 70 |
| Weight (kg) | 89 ± 17 |
| Height (cm) | 175 ± 9 |
| Body mass index (kg/m2) | 29 ± 5 |
| Body surface area (m2) | 2.0 ± 0.2 |
| Congestive heart failure (%) | 93 |
| CHA2DS2-VASc score | 3.6 ± 1.7 |
| Implantable cardioverter-defibrillator (%) | 78 |
| Cardiac resynchronisation therapy (%) | 35 |
| Arterial hypertension (%) | 66 |
| Diabetes mellitus (%) | 31 |
| Stroke/transient ischaemic attack (%) | 12 |
| Coronary (or peripheral) artery disease (%) | 68 |
| Chronic obstructive pulmonary disease (%) | 12 |
| NYHA Class | 2.0 ± 1.0 |
| NYHA Class ≥ III (%) | 31 |
| Left ventricular ejection fraction (%) | 34 ± 12 |
| Left ventricular ejection fraction < 25% (%) | 25 |
| Serum creatinine (μmol/L) | 112 ± 48 |
| Electrical storm (%) | 25 |
| PAINESD score | 11.4 ± 6.6 |
| Type of cardiomyopathy | |
| Ischaemic cardiomyopathy (%) | 67 |
| Dilated cardiomyopathy (%) | 18 |
| Arrhythmogenic cardiomyopathy (%) | 5 |
| Hypertrophic cardiomyopathy (%) | 1 |
| Valvular cardiomyopathy (%) | 11 |
| Other cardiomyopathy (%) | 13 |
Data are provided as means ± SD or percentages.
NYHA, New York Heart Association.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
